GSK Acquires Syndivia's Prostate Cancer ADC GSK has acquired the rights to Syndivia's preclinical antibody drug conjugate (ADC) for prostate cancer treatment. Despite having its own…
Bank of Canada Expected to Cut Interest Rate The Bank of Canada is expected to cut its interest rate this week due to trade uncertainty an…
Snapchat Democratizes AI Imaging Snapchat has made its first open prompt image-generation AI tool, "Imagine Lens", available to all U.S. u…
Virgin Money Launches New Products Virgin Money has announced product changes, launching tomorrow (28 October), including two-year ERC fre…
D&H Distributing’s Advanced Solutions Plus Unit To Focus On The Enterprise D&H Distributing is unveiling Advanced Solutions Plus, a new bu…
ACCC Sues Microsoft Over Alleged Misleading Subscription Practices The Australian Competition and Consumer Commission (ACCC) has filed a F…
Racial Disparities in Victim Compensation Families of Black homicide victims face higher denial rates for victim compensation claims, desp…
Childhood Psoriasis and Arthritis Risk A recent study published in the journal of Egyptian Rheumatology and Rehabilitation found that chil…
BoltzGen Democratizes AI Therapeutic Design, Expands Druggable Universe The open-source model designs therapeutics across "any" modality w…
Pirates Top 30 Prospects: Zander Mueth Pittsburgh Pirates prospect Zander Mueth aims for an injury-free 2026 season. Mueth was draf…
Meet the Next Generation of Physician Leaders at Rutgers Health In addition to their Ivy League pedigrees, it was Hailey Sulzbach’s compas…